Combined inhibition of surface CD51 and γ-secretase-mediated CD51 cleavage improves therapeutic efficacy in experimental metastatic hepatocellular carcinoma.
Cai J, Wang J, Jiang C, Ye L, He X, Huang J, Sun X, Ren Z, Lai X, Qiu Y, Wang H, Lv G, Zheng J, Lu T, Chen H, Liu Y, Chen H, Guan Y, Wang Y, Wang T, Yao J, Sui X, Kang Y, Zhang Y, Li H, Wang J, Li W, Chen G, Yang Y, Xiang AP.
Cai J, et al. Among authors: yao j.
J Hepatol. 2023 Dec;79(6):1418-1434. doi: 10.1016/j.jhep.2023.08.007. Epub 2023 Aug 19.
J Hepatol. 2023.
PMID: 37604269